From: The fading of reported effectiveness. A meta-analysis of randomised controlled trials

Pravastatin | Atorvastatin | Timolol | Latanoprost | ||
---|---|---|---|---|---|

Reported effect size* | Change in 5 years | -3.22 | +0.31 | -0.56 | -1.78 |

95% CI limits | (-4.50/-1.93) | (-3.29/+3.91) | (-0.79/-0.34) | (-3.04/-0.51) | |

Baseline^{†}
| Change in 5 years | -41.80 | -14.63 | -0.70 | -1.82 |

95% CI limits | (-55.74/-27.86) | (-48.38/+19.11) | (-1.08/-0.32) | (-3.69/+0.05) | |

Study size^{‡}
| Change in 5 years | +533.54 | +233.63 | +80.55 | -16.94 |

95% CI limits | (-3.94/+1071.01) | (-429.97/+897.23) | (+43.38/+117.71) | (-199.23/+165.35) | |

Treatment group^{§}
| Change in 5 years | -0.20 | -0.28 | -0.12 | -0.23 |

95% CI limits | (-0.31/-0.08) | (-0.58/+0.01) | (-0.17/-0.06) | (-0.50/+0.03) |